New Understanding Of Pulmonary Hypertension Leads To Promising Drug Targets

A groundbreaking new study led by researchers from the University of Pittsburgh and UPMC has identified a new group of compounds that could have robust effects in treating pulmonary hypertension (PH), an enigmatic but sometimes fatal disease of the blood vessels of the lungs that currently has no cure. The findings, which were published today in the Journal of Clinical Investigation, highlight the use of these drugs to alter vessel stiffness and its downstream control of metabolism, a link previously unknown for people suffering from the progressive disease.

“If we aim to cure this disease, the next set of medications and treatments should be those that target the origin at the molecular level,” said Stephen Y. Chan, M.D., Ph.D., director of the UPMC Center for Pulmonary Vascular Biology and Medicine at the Vascular Medicine Institute at Pitt, and senior author of the study. “As a community, we are struggling right now to understand those origins of PH, and this study aimed to address that untapped need.”

Read more: New Understanding Of Pulmonary Hypertension Leads To Promising Drug Targets

Source: bioengineer

How to Recognize a Heart Attack

Some absolutely crucial advice: how to recognize a heart attack one month before it happens

Did you know that the main cause of early death in the US are heart attacks? The stressful way of life and the junk food we keep eating is a great contributor for this illness becoming so common and so dangerous over the last years.

Leading a healthy lifestyle and trying to decrease the levels of stress in your life can help protect you from heart failure, but another thing that can be very useful, even lifesaving, is knowing the symptoms of heart failure a month before it happens.

These are the symptoms that you might have a heart attack in a month. Make sure you always treat these as red flags.

Read more: How to Recognize a Heart Attack

Source: brightside

Blood Vessel-Forming Protein Could Offer Alternative to Heart Bypass Surgery

For patients with severe coronary artery disease, heart bypass surgery can reduce the risk of heart attack and improve overall quality of life. Now, researchers report the possibility of a new treatment that may be even more beneficial, without the surgery.

Coronary artery disease (CAD) is the most common form of heart disease in the United States, responsible for more than 370,000 deaths in the country every year.

The condition arises when plaque builds up in the coronary arteries, partially or fully blocking the flow of oxygen-rich blood to the heart muscle. This blockage can cause heart attack, angina - severe chest pain - and, over time, heart failure.

While lifestyle changes - such as adopting a healthy diet and regular physical activity - are considered key to improving CAD, some patients may require heart bypass surgery, which can help restore blood flow to the heart.

But, as with all surgery, it has its risks. These include chest wound infection, bleeding, stroke, heart attack, and kidney or lung failure.

Read more: Blood Vessel-Forming Protein Could Offer Alternative to Heart Bypass Surgery

Researchers say the protein AGGF1 could be a promising treatment for coronary heart disease and
heart attack.

Source: medicalnewstoday

Heart Transplantation Recipients Unaffected by Donor Troponin Levels

Many transplant centers routinely reject hearts if the donor’s blood test reveals elevated levels of troponin I, a protein found in heart muscle that enters the bloodstream when there is a heart attack or other heart muscle damage. Donors with previous heart disease are automatically excluded.

Heart transplantation is one of the greatest achievements in modern medicine and patients with advanced heart failure in whom survival is measured in weeks and months are offered the potential for survival of equal to or greater than 10 years with excellent quality of life.

Read more: Heart Transplantation Recipients Unaffected by Donor Troponin Levels

According to new research, a blood test that leads to donor hearts being rejected may not effectively
predict whether a heart transplant will succeed or fail (Photo courtesy of the AMA).

Source: labmedica

Donor Blood Test May be Holding Back Heart Transplantation

A blood test used to determine whether a heart is suitable for donation may be leading to unnecessary rejections, and its use should be reviewed. This is the conclusion of a new study published in the journal Circulation: Heart Failure.

Heart failure occurs when the heart is unable to pump enough oxygen-rich blood around the body to help other organs function.

According to the Centers for Disease Control and Prevention (CDC), in the United States, around 5.7 million Americans have heart failure.

In some cases, heart failure can be treated with lifestyle changes - such as a healthy diet, exercise, and quitting smoking - and medications. For end-stage heart failure, however, a heart transplant may be the only option.

Read more: Donor Blood Test May be Holding Back Heart Transplantation

Determining whether a heart is suitable for transplantation based on donor troponin I levels may be
causing unnecessary rejections, say researchers.

Source: medicalnewstoday